Vaccinex (VCNX) Short Interest Ratio & Short Volume → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free VCNX Stock Alerts $5.01 +0.05 (+1.01%) (As of 05:22 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Vaccinex Short Interest DataCurrent Short Volume6,300 sharesPrevious Short Volume8,800 sharesChange Vs. Previous Month-28.41%Dollar Volume Sold Short$46,683.00Short Interest Ratio / Days to Cover0.5Last Record DateMarch 31, 2024Outstanding Shares1,230,000 sharesFloat Size539,400 sharesShort Percent of Float1.17%Today's Trading Volume3,504 sharesAverage Trading Volume11,566 sharesToday's Volume Vs. Average30% Short Selling Vaccinex ? Sign up to receive the latest short interest report for Vaccinex and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVCNX Short Interest Over TimeVCNX Days to Cover Over TimeVCNX Percentage of Float Shorted Over Time Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. Vaccinex Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20246,300 shares $46,683.00 -28.4%1.2%0.5 $7.41 3/15/20248,800 shares $70,840.00 -40.5%1.5%0.8 $8.05 2/29/202414,800 shares $130,240.00 +21.3%2.5%1.4 $8.80 2/15/202412,200 shares $149,450.00 -55.6%3.0%1.2 $12.25 1/31/202427,500 shares $17,201.25 -26.3%0.4%0.3 $0.63 1/15/202437,300 shares $21,596.70 -55.9%0.6%0.4 $0.58 Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 12/31/202384,600 shares $56,242.08 +593.4%1.3%0.2 $0.66 12/15/202312,200 shares $6,679.50 -45.3%0.2%0 $0.55 11/30/202322,300 shares $16,702.70 -55.8%0.4%0 $0.75 11/15/202350,400 shares $45,360.00 +32.3%0.8%0.1 $0.90 10/31/202338,100 shares $36,614.10 -80.8%0.6%0.1 $0.96 10/15/2023198,000 shares $207,900.00 -37.8%3.1%0.3 $1.05 9/30/2023318,400 shares $359,792.00 +2,080.8%5.0%0.6 $1.13 9/15/202314,600 shares $40,274.10 -88.8%0.7%0.5 $2.76 8/31/2023130,400 shares $26,471.20 +11.7%N/A0.9 $0.20 8/15/2023116,700 shares $27,436.17 -36.9%N/A0.6 $0.24 7/31/2023184,900 shares $53,639.49 -44.8%N/A0.9 $0.29 7/15/2023334,900 shares $103,919.47 +204.5%N/A1.7 $0.31 6/30/2023110,000 shares $39,160.00 -49.7%0.5%0.6 $0.36 6/15/2023218,600 shares $96,184.00 +119.7%1.0%1.5 $0.44 5/31/202399,500 shares $40,307.45 -30.5%0.5%0.7 $0.41 5/15/2023143,100 shares $57,240.00 -4.1%0.8%1.4 $0.40 4/30/2023149,200 shares $53,712.00 +16.0%0.6%0.3 $0.36 4/15/2023128,600 shares $55,580.92 -16.7%0.6%0.3 $0.43 3/31/2023154,400 shares $61,682.80 -9.9%0.7%0.3 $0.40 3/15/2023171,400 shares $71,148.14 -34.2%0.7%0.4 $0.42 2/28/2023260,300 shares $128,588.20 -27.0%1.0%0.5 $0.49 2/15/2023356,600 shares $180,083.00 +161.3%1.4%0.7 $0.51 1/31/2023136,500 shares $81,217.50 +27.2%0.7%0.3 $0.60 1/15/2023107,300 shares $68,135.50 -53.1%0.6%1.9 $0.64 12/30/2022229,000 shares $147,590.50 +22.8%1.3%4.1 $0.64 12/15/2022186,500 shares $130,755.15 +50.5%1.0%3.2 $0.70 11/30/2022123,900 shares $61,974.78 -4.6%0.7%1.7 $0.50 11/15/2022129,900 shares $74,043.00 -50.9%0.6%1.8 $0.57 10/31/2022264,300 shares $156,994.20 +35.8%1.1%3.3 $0.59 10/15/2022194,600 shares $104,111.00 +127.3%0.9%1.3 $0.54 9/30/202285,600 shares $42,372.00 -30.2%0.4%0.6 $0.50 9/15/2022122,600 shares $96,976.60 -6.3%0.6%0.9 $0.79 8/31/2022130,800 shares $113,429.76 -29.5%0.6%1 $0.87 8/15/2022185,400 shares $198,378.00 -11.7%0.9%1.2 $1.07Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report VCNX Short Interest - Frequently Asked Questions What is Vaccinex's current short interest? Short interest is the volume of Vaccinex shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 6,300 shares of VCNX short. 1.17% of Vaccinex's shares are currently sold short. Learn More on Vaccinex's current short interest. What is a good short interest percentage for Vaccinex? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.17% of Vaccinex's floating shares are currently sold short. Is Vaccinex's short interest increasing or decreasing? Vaccinex saw a drop in short interest in March. As of March 31st, there was short interest totaling 6,300 shares, a drop of 28.4% from the previous total of 8,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vaccinex's float size? Vaccinex currently has issued a total of 1,230,000 shares. Some of Vaccinex's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vaccinex currently has a public float of 539,400 shares. How does Vaccinex's short interest compare to its competitors? 1.17% of Vaccinex's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Vaccinex: Avenue Therapeutics, Inc. (0.64%), Hoth Therapeutics, Inc. (5.00%), Protagenic Therapeutics, Inc. (0.32%), First Wave BioPharma, Inc. (3.04%), Xenetic Biosciences Inc (0.14%), Cadrenal Therapeutics, Inc. (0.50%), Oragenics, Inc. (2.07%), Ainos, Inc. (4.81%), Exicure, Inc. (2.40%), Alzamend Neuro, Inc. (0.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Vaccinex stock? Short selling VCNX is an investing strategy that aims to generate trading profit from Vaccinex as its price is falling. VCNX shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vaccinex? A short squeeze for Vaccinex occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VCNX, which in turn drives the price of the stock up even further. How often is Vaccinex's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VCNX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Avenue Therapeutics Short Squeeze Hoth Therapeutics Short Squeeze Protagenic Therapeutics Short Squeeze First Wave BioPharma Short Squeeze Xenetic Biosciences Short Squeeze Cadrenal Therapeutics Short Squeeze Oragenics Short Squeeze Ainos Short Squeeze Exicure Short Squeeze Alzamend Neuro Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VCNX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressPentagon contract could send this $2 AI stock soaringBehind the MarketsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals